New Diagnosis? Start Here



January 14, 2016

MDF just kicked off the new year with our annual two-day strategic planning offsite. The planning team included DM researchers, board members and staff. Read on for some highlights of our plans for 2016 and progress to date on our 3-year drug development acceleration effort, MDF 3.0: Driving Drug Development.

January 13, 2016

This year’s MDF Annual Conference will be held Thursday, September 15 - Saturday, September 17, 2016 in Washington, DC. In addition to an expanded array of research, drug development, disease management and community networking programs, this year MDF will host the first community meeting focused on the Food and Drug Administration (FDA). MDF community members will educate the FDA and other federal agency representatives about symptoms and disease issues that are most important to patients and families, and guide their thinking on DM drug review. Don’t miss this one-time opportunity – we need your voice!

December 30, 2015

Many MDF community members are aware of an important, multi-year MDF effort -- MDF 3.0: Accelerating Drug Development -- because we published an article on the launch of this initiative in early 2015. Read a full report on the first-year results of MDF 3.0: Accelerating Drug Development, and the initiatives we are pursuing to promote the development of new DM therapies.  


© Myotonic Dystrophy Foundation. All rights reserved.